CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case-control study.
Figueiras A, Estany-Gestal A, Aguirre C, Ruiz B, Vidal X, Carvajal A, Salado I, Salgado-Barreira A, Rodella L, Moretti U, Ibáñez L; EMPHOGEN group.
Figueiras A, et al. Among authors: moretti u.
Pharmacogenet Genomics. 2016 Feb;26(2):66-73. doi: 10.1097/FPC.0000000000000186.
Pharmacogenet Genomics. 2016.
PMID: 26544900
Free PMC article.